Back for its 24th Annual Edition, this global bio-pharma industry event will address the main challenges in investment for 2024 as well as partnering and alliance management and prospects for 2025. Key players will contribute their insights in panels, which will cover the macro picture as well as innovation in different therapeutic sectors.
Meet with our drug substance and drug product experts in this event, Christina Dreher, and Raja Yekkala and discover how our integrated CDMO services can accelerate your development programs.
